NEW YORK (GenomeWeb News) - Invitrogen said today that it has licensed intellectual property from the Wisconsin Alumni Research Foundation that will enable it to develop research tools using human embryonic stem cells.
 
Under the terms of the agreement, the licensing organization for the University of Wisconsin-Madison has granted Invitrogen the right to work with karyotypically normal hESCs to develop research and drug discovery tools.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.